Artificial Intelligence and Panendoscopy — Automatic Detection of Clinically Relevant Lesions in Multibrand Device-Assisted Enteroscopy

Exciting News to kick off 2024! The beginning of the year brings tremendous updates for DigestAID. Delighted to share that our groundbreaking paper, “Artificial Intelligence and Panendoscopy—Automatic Detection of Clinically Relevant Lesions in Multibrand Device-Assisted Enteroscopy,” is now featured in the esteemed Cancers MDPI Journal (Q1 Oncology).

Our Deep Bowel technology is revolutionizing diagnostics with an interoperable CNN, setting a new standard by providing an AI-guided panendoscopic exam for diagnostic and therapeutic procedures across the entire gastrointestinal tract. Join us in a transformative 2024, shaping the future of healthcare. Together, let’s make this year a milestone in healthcare innovation, advancing precision-based medicine and transforming patient outcomes!

Discover more from DigestAID

Subscribe now to keep reading and get access to the full archive.

Continue reading